Middle East Journal of Rehabilitation and Health

Published by: Kowsar

Investigating the Effects of Regular Resistance Training and Prostatic Massage on Proinflammatory Markers and Serum Prostate-Specific Antigen Levels in Males with Prostate Cancer

Fazllolah Fathollahi Shoorabeh 1 , * , Valiolah Dabidiroshan 2 , Bahareh Sheikh Saraf 3 and Reza Nuri 4
Authors Information
1 Department of Sport Physiology, Shahrekord University, Shahrekord, IR Iran
2 Department of Sport Physiology, University of Mazandaran, Babolsar, IR Iran
3 Department of physical Education, Nejafabad Branch, Islamic Azad University, Isfahan, IR Iran
4 Department of Exercise Physiology, Kish International Campus, University of Tehran, kish, IR Iran
Article information
  • Middle East Journal of Rehabilitation and Health: January 01, 2016, 3 (1); e33651
  • Published Online: January 24, 2016
  • Article Type: Research Article
  • Received: October 6, 2015
  • Revised: November 10, 2015
  • Accepted: December 14, 2015
  • DOI: 10.17795/mejrh-33651

To Cite: Fathollahi Shoorabeh F, Dabidiroshan V, Sheikh Saraf B, Nuri R. Investigating the Effects of Regular Resistance Training and Prostatic Massage on Proinflammatory Markers and Serum Prostate-Specific Antigen Levels in Males with Prostate Cancer, Middle East J Rehabil Health Stud. 2016 ; 3(1):e33651. doi: 10.17795/mejrh-33651.

Abstract
Copyright © 2016, Semnan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
References
  • 1. Fazeli F, Nowroozi MR, Ayati M, Latifi S, Mahmoodi MT, Javidan AN, et al. Comparison of the efficacy of two brands of triptorelin (microrelin and diphereline) in reducing prostate-specific antigen and serum testosterone in prostate cancer: A double-blinded randomized clinical trial. Nephro-Urol. 2015; 7(3)
  • 2. Ferrer BCS, Bosch PM, Del Valle A. Physical exercise as complementary treatment in prostate cancer. Apunts. 2010; 45(166): 81-93
  • 3. Keogh JWL, MacLeod RD. Body composition, physical fitness, functional performance, quality of life, and fatigue benefits of exercise for prostate cancer patients: A systematic review. J Pain Symptom Manage. 2012; 43(1): 96-110[DOI]
  • 4. Spry NA, Kristjanson L, Hooton B, Hayden L, Neerhut G, Gurney H, et al. Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer. Eur J Cancer. 2006; 42(8): 1083-92[DOI]
  • 5. Tarhan F, Orcun A, Kucukercan I, Camursoy N, Kuyumcuoglu U. Effect of prostatic massage on serum complexed prostate-specific antigen levels. Urology. 2005; 66(6): 1234-8[DOI]
  • 6. Galvao DA, Taaffe DR, Spry N, Joseph D, Newton RU. Combined resistance and aerobic exercise program reverses muscle loss in men underagoiang androgen suppression therapy for prostate cancer without bone metastases: A randomized controlled trial. Eur J Cancer. 2009; 28(2): 340-7[DOI]
  • 7. von Hertzen LC, Joensuu H, Haahtela T. Microbial deprivation, inflammation and cancer. Cancer Metastasis Rev. 2011; 30(2): 211-23[DOI]
  • 8. Chughtai B, Lee R, Te A, Kaplan S. Role of inflammation in benign prostatic hyperplasia. Nat Rev Urol. 2011; 13(3): 147
  • 9. Coventry BJ, Ashdown ML, Quinn MA, Markovic SN, Yatomi-Clarke SL, Robinson AP. CRP identifies homeostatic immune oscillations in cancer patients: A potential treatment targeting tool? J Transl Med. 2009; 7(1): 102[DOI]
  • 10. McDowell ME, Occhipinti S, Gardiner RA, Baade PD, Steginga SK. A review of prostate-specific antigen screening prevalence and risk perceptions for first-degree relatives of men with prostate cancer. Eur J Cancer Care . 2009; 18(6): 545-55[DOI]
  • 11. Lee S, Choe JW, Kim HK, Sung J. High-sensitivity C-reactive protein and cancer. J Cancer Epidemiol. 2011; 21(3): 161-8
  • 12. Richardsen E, Uglehus R, Due J, Busch C, Busund LT. COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-β, IL-10 and Ki67. J Cancer Epidemiol. 2010; 34(3): 316-22[DOI]
  • 13. Michaud DS. Genetic Polymorphisms of Interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and Risk of Prostate Cancer. Am J Cancer . 2006; 66(8): 4525-30[DOI]
  • 14. Eder T, Mayer R, Langsenlehner U, Renner W, Krippl P, Wascher TC, et al. Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: A population-based study. Eur J Cancer. 2007; 43(3): 472-5[DOI]
  • 15. Malagarie-Cazenave S, Olea-Herrero N, Vara D, Morell C, Díaz-Laviada I. The vanilloid capsaicin induces IL-6 secretion in prostate PC-3 cancer cells. Cytokine. 2011; 54(3): 330-7[DOI]
  • 16. Liu XH, Kirschenbaum A, Lu M, Yao S, Klausner A, Preston C, et al. Prostaglandin E2 Stimulates Prostatic Intraepithelial Neoplasia Cell Growth through Activation of the Interleukin-6/GP130/STAT-3 Signaling Pathway. Biochem Biophys Res Commun. 2002; 290(1): 249-55[DOI]
  • 17. Spiotto MT, Chung TDK. STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells. The Prostate. 2000; 42(3): 186-95[DOI]
  • 18. GalvAo DA, Newton RU, Taaffe DR, Spry N. Can exercise ameliorate the increased risk of cardiovascular disease and diabetes associated with ADT? Nat Clin Pract Urol. 2008; : 306-7[DOI]
  • 19. Segal RJ. Resistance Exercise in Men Receiving Androgen Deprivation Therapy for Prostate Cancer. Am J Clin Oncol. 2003; 21(9): 1653-9[DOI]
  • 20. Daniel AG, Kazunori N, Dennis RT, Nigel S, Linda JK, Michael RM, et al. Resistance training and reduction of treatment side effects in prostate cancer . Med Sci Sports Exercise. 2006; 38(12): 2045-52
  • 21. Culos-Reed SN, Robinson JW, Lau H, Stephenson L, Keats M, Norris S, et al. Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention. Supp Care Cancer. 2009; 18(5): 591-9[DOI]
  • 22. Krohn M, Listing M, Tjahjono G, Reisshauer A, Peters E, Klapp BF, et al. Depression, mood, stress, and Th1/Th2 immune balance in primary breast cancer patients undergoing classical massage therapy. Supp. Care Cancer. 2010; 19(9): 1303-11[DOI]
  • 23. Listing M, Reißhauer A, Voigt B, Klapp B, Rauchfuß M. Massage in der Versorgung von Brustkrebspatientinnen - Eine systematische Analyse der aktuellen Studienlage. Geburtshilfe Frauenheilkd. 2008; 68(4): 359-69[DOI]
  • 24. Nickel JC, Nyberg LM, Hennenfent M. Research guidelines for chronic prostatitis: consensus report from the First National Institutes of Health International Prostatitis Collaborative Network. Urology. 1999; 54(2): 229-33[DOI]
  • 25. Schenk JM, Kristal AR, Neuhouser ML, Tangen CM, White E, Lin DW, et al. Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: Results from the prostate cancer prevention trial. Am J Epidemiol. 2010; 171(5): 571-82[DOI]
  • 26. Srinivasan S, Kumar R, Koduru S, Chandramouli A, Damodaran C. Inhibiting TNF-mediated signaling: a novel therapeutic paradigm for androgen independent prostate cancer. Apoptosis. 2009; 15(2): 153-61[DOI]
  • 27. Oberpenning F, Schmid HP, Fuchs-Surdel W, Hertle L, Semjonow A. The impact of intraoperative manipulation of the prostate on total and free prostate-specific antigen. Int J Biol Markers. 2002; 17(3): 154-60[PubMed]
  • 28. Segal RJ, Reid RD, Courneya KS, Sigal RJ, Kenny GP, Prud'Homme DG, et al. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J Clin Oncol. 2009; 27(3): 344-51[DOI][PubMed]
  • 29. Mechergui YB, Ben Jemaa A, Mezigh C, Fraile B, Ben Rais N, Paniagua R, et al. The profile of prostate epithelial cytokines and its impact on sera prostate specific antigen levels. Inflammation. 2009; 32(3): 202-10[DOI][PubMed]
  • 30. Hernandez-Reif M, Ironson G, Field T, Hurley J, Katz G, Diego M, et al. Breast cancer patients have improved immune and neuroendocrine functions following massage therapy. J Psychosom Res. 2004; 57(1): 45-52[DOI]
  • 31. Ito M, Saito K, Yasuda Y, Sukegawa G, Kubo Y, Numao N, et al. Prognostic impact of C-reactive protein for determining overall survival of patients with castration-resistant prostate cancer treated with docetaxel. Urology. 2011; 78(5): 1131-5[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments